Abstract:Abstract Background Limited information exists on postoperative hypocortisolism and hypothalamus–pituitary–adrenal axis recovery in patients with adrenal incidentaloma following unilateral adrenalectomy. We evaluated frequency of postoperative hypocortisolism and predictors for recovery in non-aldosterone-producing adrenocortical adenoma patients after unilateral adrenalectomy. Methods A retrospective analysis of 32 adrenal incidentaloma patients originally included in the ITACA trial (NCT04127552) with confirmed non-aldosterone-producing adrenocortical adenoma undergoing unilateral adrenalectomy from September 2019 to April 2023 was conducted. Preoperative assessments included adrenal MRI, anthropometrics, evaluation of comorbidities, adrenal function assessed via ACTH, urinary free cortisol, and 1 mg dexamethasone suppression test. ACTH and serum cortisol or Short Synacthen test were performed within 6 days, 6 weeks, 6 months, and a year after surgery. Results Six days postoperative, 18.8% of patients had normal adrenal function. Among those with postoperative hypocortisolism, 53.8% recovered by 6 weeks. Patients with earlier adrenal recovery (6 weeks) had lower preoperative 1 mg dexamethasone suppression test (median 1 mg dexamethasone suppression test 76.2 [61.8–111.0] nmol/L vs 260.0 [113.0–288.5] nmol/L, p < 0.001). Univariate analysis showed preoperative 1 mg dexamethasone suppression test negatively related with baseline ACTH levels ( r = − 0.376; p = 0.041) and negatively associated with the 6-week baseline ( r = − 0.395, p = 0.034) and 30-min cortisol levels during Short Synacthen test ( r = − 0.534, p = 0.023). Logistic regression analysis demonstrated preoperative 1 mg dexamethasone suppression test as the only biochemical predictor for 6-week adrenal recovery: ROC curve identified a 1 mg dexamethasone suppression test threshold of 131 nmol/L predicting 6-week recovery with 89.5% sensitivity and 72.7% specificity (AUC 0.87; 95% CI 66.9–98.7, p < 0.001). Other preoperative assessments (tumor size, ACTH levels and anthropometrics) were not associated with postoperative hypothalamus–pituitary–adrenal axis function, but the presence of diabetes was associated with a lower probability of recovery (OR = 24.55, p = 0.036). ACTH levels increased postoperatively in all patients but did not predict hypothalamus–pituitary–adrenal axis recovery. Conclusions The preoperative 1 mg dexamethasone suppression test cortisol value and presence of diabetes are the only relevant predictor of hypothalamus–pituitary–adrenal axis recovery in patients with non-aldosterone- producing adrenocortical adenoma undergoing surgery, regardless other clinical and biochemical variables. Notably, pre- and postoperative ACTH levels did not predict hypothalamus–pituitary–adrenal axis recovery. These findings point towards the potential for saving resources by optimizing their allocation during follow-up assessments for patients with non-aldosterone-producing adrenocortical adenoma undergoing unilateral adrenalectomy.

On the Postoperative Steroid Replacement in Patients with ACTH Independent Cushing's Syndrome

A Study on Perioperative Steroid Replacement for Cushing's Syndrome

A Study on Perioperative Endocrine Therapy for Retroperitoneal Laparoscopic Adrenalectomy of Cushing's Syndrome

Application of Hydrocortisone during Perioperation of Cushing's Syndrome after Laparoscopic Opera-tion

ODP639 The Occurrence and Predictors of Postoperative Adrenal Insufficiency for Patients With Subclinical Cushing's Syndrome

Glucocorticoid replacement therapy after retroperitoneal laparoscopic unilateral adrenal adenoma resection in patients with non-cortisol secreting tumors: a retrospective cohort study

Predictor of Steroid Replacement Duration after Removal of Cortisol-producing Adenoma

The Clinical Analysis of Severe Adrenal Cushing′s Syndrome

Is Peri-Operative Steroid Replacement Therapy Necessary For The Pituitary Adenomas Treated With Surgery? A Systematic Review And Meta Analysis

The rapid tapering glucocorticoids replacement perioperatively on adrenocortical adenoma related Cushing's syndrome:a prospective study

Preoperative Prognostic Nomogram for Prophylactic Steroid Treatment of Patients with Subclinical Cushing’s Syndrome

Perioperative Management of a Patient With Cushing Disease

Alternative Necessity of Perioperative Glucocorticoid for Resection of Pituitary Adenomas Via Sphenoid Sinus

The Diagnosis and Surgical Treatment of Pituitary ACTH- secreting Cushing’s Adenoma

The Role of Unilateral Adrenalectomy in Corticotropin-Independent Bilateral Adrenocortical Hyperplasias

Adrenal Gland Surgery in the Treatment of Hyperadrenocorticism Curative Effect Appraisal

The Recovery Time of Hypothalamic-Pituitary-adrenal Axis after Curative Surgery in Cushing's Disease and Its Related Factor

Surgical treatment of corticotropin-independent bilateral adrenocortical hyperplasias

Analysis of the influencing factors of the recurrence of Cushing′s disease after transsphenoidal surgery

Predicting postoperative hypocortisolism in patients with non-aldosterone-producing adrenocortical adenoma: a retrospective single-centre study

Surgical Treatment of Ectopic Adrenocorticotropic Hormone Syndrome with Intra-Thoracic Tumor.